X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Exploring the new era of medicine

By Bill Chin, M.D.  |    February 21, 2017
We are in a new era of medicine where innovations are transforming our ability to attack the cause of disease, not just the symptoms. Where treatment decisions are increasingly focused on the...   Read More

Watch: Biomarkers in drug development with Dr. Bernie Zeiher

By Andrew Powaleny  |    February 14, 2017
Biomarkers are powerful tools which are used by medical professionals in many ways, including in the diagnosis of disease, monitoring how a disease is progressing and, if a treatment is given, how...   Read More

Video: Translating science into new medicines

By Andrew Powaleny  |    December 12, 2016
Researchers and scientists at America’s biopharmaceutical companies and around the globe work every day to translate science into new treatments and cures to allow patients to live longer,...   Read More

Reflecting on terrific progress in treating diabetes

By Bill Chin, M.D.  |    November 17, 2016
There is no doubt that diabetes is a complex disease to diagnose and treat. That’s something I’ve seen firsthand as an endocrinologist. Over the years, I treated a number of patients that had a...   Read More

Continuing progress and promise in pediatric drug development

By Guest Contributor  |    November 15, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Harnessing the power of real-world evidence to benefit patients through PDUFA VI

By Andrew Powaleny  |    September 6, 2016
America’s biopharmaceutical researchers are in a golden era of medical research, discovery and development for patients. Rapid advances in technology and science have enhanced our ability to use...   Read More

Improving FDA’s combination product review process could increase epinephrine auto-injector competition

By Stephen J. Ubl  |    August 30, 2016
Combination products that consist of a medicine and delivery device are important treatment options for patients and have the potential to improve public health. Innovator companies invest in...   Read More

In biopharmaceutical research, if at first you don’t succeed, try again

By Andrew Powaleny  |    August 17, 2016
In case you missed it, an article in STAT News today profiles setbacks inside the process of researching new treatments and cures for patients. For America’s biopharmaceutical research companies,...   Read More

Dr. George Scangos: Not just science for science’s sake

By Andrew Powaleny  |    August 10, 2016
America’s biopharmaceutical researchers are working tirelessly to develop new and innovative medicines for patients. For those diseases that have no treatment options, the opportunity to improve...   Read More

What you need to know about PDUFA VI

By Andrew Powaleny  |    July 27, 2016
The U.S. Food and Drug Administration (FDA) recently released its performance goals letter for the sixth installment of the Prescription Drug User Fee Act (PDUFA). The letter comes after months of...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates